Meta-analysis of procalcitonin for sepsis detection

Lancet Infectious Diseases

Volumn 7, Issue 8, 2007, Pages 500-502

  Reinhart, Konrad ^a   Brunkhorst, Frank M ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; BIOLOGICAL MARKER; PROCALCITONIN;

ANTIMICROBIAL THERAPY; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE SEVERITY; HUMAN; LETTER; MEDICAL DECISION MAKING; PRIORITY JOURNAL; PUBLISHING; SAMPLE SIZE; SENSITIVITY AND SPECIFICITY; SEPSIS; SEPTIC SHOCK; THERAPY DELAY; TREATMENT OUTCOME;

BIOLOGICAL MARKERS; CALCITONIN; DIAGNOSIS, DIFFERENTIAL; HUMANS; META-ANALYSIS; PREDICTIVE VALUE OF TESTS; PROTEIN PRECURSORS; SELECTION BIAS; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 34447553695     PISSN: 14733099     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1473-3099(07)70165-2     Document Type: Letter

References (15)

1. Tang B., Eslick G., Craig J., and McLean A. Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis. Lancet Infect Dis 7 (2007) 210-217
2. Brunkhorst F., Eberhard O., and Brunkhorst R. Discrimination of infectious and noninfectious causes of early acute respiratory distress syndrome by procalcitonin. Crit Care Med 27 (1999) 2172-2176
3. Rau B., Steinbach G., Gansauge F., Mayer J., Grunert A., and Beger H. The potential role of procalcitonin and interleukin 8 in the prediction of infected necrosis in acute pancreatitis. Gut 41 (1997) 832-840
4. Kuse E., Langefeld I., Jaeger K., and Kulpmann W. Procalcitonin in fever of unknown origin after liver transplantation: a variable to differentiate acute rejection from infection. Crit Care Med 28 (2000) 555-559
5. Bone R., Balk R., Cerra F., et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101 (1992) 1644-1655
6. Levy M., Fink M., Marshall J., et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med 29 (2003) 530-538
7. Engel C., Brunkhorst F., Bone H., et al. Epidemiology of sepsis in Germany: results from a national prospective multicenter study. Intensive Care Med 33 (2007) 606-618
8. Kumar A., Roberts D., Wood K., et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 34 (2006) 1589-1596
9. Uzzan B., Cohen R., Nicolas P., Cucherat M., and Perret G. Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis. Crit Care Med 34 (2006) 1996-2003
10. Simon L., Gauvin F., Amre D., Saint-Louis P., and Lacroix J. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis 39 (2004) 206-217
11. Harbarth S., Holeckova K., Froidevaux C., et al. Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med 164 (2001) 396-402
12. Christ-Crain M., Jaccard-Stolz D., Bingisser R., et al. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Lancet 363 (2004) 600-607
13. Christ-Crain M., Stolz D., Bingisser R., et al. Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial. Am J Respir Crit Care Med 174 (2006) 84-93
14. Reinhart K., Meisner M., and Brunkhorst F. Markers for sepsis diagnosis: what is useful?. Crit Care Clin 22 (2006) 503-519 ix-x.
15. Jensen J., Heslet L., Jensen T., Espersen K., Steffensen P., and Tvede M. Procalcitonin increase in early identification of critically ill patients at high risk of mortality. Crit Care Med 34 (2006) 2596-2602